Goldman Sachs Starts Lifestance Health Group (LFST) at Neutral

Go back to Goldman Sachs Starts Lifestance Health Group (LFST) at Neutral

Morgan Stanley Starts Lifestance Health Group (LFST) at Overweight

July 6, 2021 12:52 AM EDT

Morgan Stanley analyst Ricky Goldwasser initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.

The analyst comments "We apply a 11.5x EV/22revenue multiple to our base case 2023 $1.2b revenue estimate,a +1x turn... More

JPMorgan Starts Lifestance Health Group (LFST) at Overweight

July 6, 2021 12:50 AM EDT

JPMorgan analyst Lisa Gill initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Overweight rating and a price target of $36.00.

The analyst comments "The largest outpatient behavioral health platform in the U.S., LifeStance aims to disrupt the traditional model which suffers from: 1) low... More